Viewing Study NCT04652206

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2026-01-21 @ 8:04 PM
Study NCT ID: NCT04652206
Status: UNKNOWN
Last Update Posted: 2021-12-29
First Post: 2020-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.
Sponsor: Scandion Oncology A/S
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Adenocarcinoma View
None Locally Advanced Pancreatic Adenocarcinoma View
None Inoperable Disease View
None Localized Pancreatic Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pancreatic View
None cancer View
None non-resectable View
None inoperable View
None pancreatic adenocarcinoma View